| EULAR recommendations for the management of primary small and medium vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 310-317, 2009 | 1278 | 2009 |
| EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics … B Combe, R Landewé, C Lukas, HD Bolosiu, F Breedveld, M Dougados, ... Annals of the rheumatic diseases 66 (1), 34-45, 2007 | 1185 | 2007 |
| The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center E Kural-Seyahi, I Fresko, N Seyahi, Y Ozyazgan, C Mat, V Hamuryudan, ... Medicine 82 (1), 60-76, 2003 | 1013 | 2003 |
| EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 995 | 2008 |
| A controlled trial of azathioprine in Behcet's syndrome H Yazici, H Pazarli, CG Barnes, Y Tüzün, Y Özyazgan, A Silman, ... New England Journal of Medicine 322 (5), 281-285, 1990 | 853 | 1990 |
| EULAR recommendations for the management of large vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 318-323, 2009 | 843 | 2009 |
| 2018 update of the EULAR recommendations for the management of Behçet’s syndrome G Hatemi, R Christensen, D Bang, B Bodaghi, AF Celik, F Fortune, ... Annals of the rheumatic diseases 77 (6), 808-818, 2018 | 771 | 2018 |
| EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis B Hellmich, O Flossmann, WL Gross, P Bacon, JW Cohen-Tervaert, ... Annals of the rheumatic diseases 66 (5), 605-617, 2007 | 708 | 2007 |
| Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome: a randomized, double-blind, placebo-controlled trial V Hamuryudan, C Mat, S Saip, Y Ozyazgan, A Siva, S Yurdakul, ... Annals of internal medicine 128 (6), 443-450, 1998 | 599 | 1998 |
| Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. H Yazici, Y Tüzün, H Pazarli, S Yurdakul, Y Ozyazgan, H Ozdoğan, ... Annals of the rheumatic diseases 43 (6), 783-789, 1984 | 571 | 1984 |
| Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, ... Annals of the rheumatic diseases 67 (7), 1004-1010, 2008 | 510 | 2008 |
| A double‐blind trial of colchicine in Behçet's syndrome S Yurdakul, C Mat, Y Tüzün, Y Özyazgan, V Hamuryudan, Ö Uysal, ... Arthritis & Rheumatism 44 (11), 2686-2692, 2001 | 482 | 2001 |
| Behçet syndrome: a contemporary view H Yazici, E Seyahi, G Hatemi, Y Yazici Nature Reviews Rheumatology 14 (2), 107-119, 2018 | 432 | 2018 |
| Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ... Rheumatology 46 (5), 736-741, 2007 | 431 | 2007 |
| Behçet's disease: diagnostic and prognostic aspects of neurological involvement A Siva, OH Kantarci, S Saip, A Altintas, V Hamuryudan, C Islak, N Koçer, ... Journal of neurology 248, 95-103, 2001 | 425 | 2001 |
| Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. M Melikoglu, I Fresko, C Mat, Y Ozyazgan, F Gogus, S Yurdakul, ... The Journal of Rheumatology 32 (1), 98-105, 2005 | 421 | 2005 |
| Behçet's syndrome Y Yazici, I Simsek, H Yazici Inflammatory Diseases of Blood Vessels, 289-298, 2012 | 408* | 2012 |
| Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases V Hamuryudan, S Yurdakul, F Moral, F Numan, H Tüzün, N Tüzüner, ... Rheumatology 33 (1), 48-51, 1994 | 405 | 1994 |
| Azathioprine in Behçet's syndrome. Effects on long‐term prognosis V Hamuryudan, Y Özyazgan, N Hizli, C Mat, S Yurdakul, Y Tüzün, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 388 | 1997 |
| Behçet's syndrome: disease manifestations, management, and advances in treatment H Yazici, I Fresko, S Yurdakul Nature clinical practice Rheumatology 3 (3), 148-155, 2007 | 375 | 2007 |
